Votre navigateur ne supporte pas le javascript Wallonia & Brussels against COVID-19 - Technology & devices

Technology & devices

Alain Vigneron, Founder & Scientific advisor - Benoît Autem, CEO - Nicolas Bodart, R&D Director - Bernard Noirhomme, Business development Manager

D-tek s.a
" "Multiplex Immuno-Dot technology for COVID-19 serological investigation The Multiplex serological technology, developed since 1995 in D-tek (www.d-tek.be), is dedicated to the profiling of the human antibody response to different immunogens, in a single test. It has various applications in laboratory diagnostics, as well as medical and pharmaceutical research (companion-diagnostics). The technology finds an obvious application for the COVID-19 serological investigation, as the antibody response to the SARS-CoV-2 infection is known to be complex, with multi-epitope targeting, and needs to be better understood. In a typical test (ongoing development), various recombinant SARS-CoV-2 antigens are coated on a membrane strip at different spot positions. The assay is designed to map, in one single test, any patient antibody recognizing any of these protein structures. The test procedure is a classical enzyme immunoassay that can be processed from 10µl of patient's serum or...

Alfred Attipoe, CEO

Comunicare Solutions
" Comunicare Solutions is a health technology startup, specializing in patient empowerment, self-management and digital therapy. In the context of Covid-19 sanitary crisis, we proposed our solution for the remote support to chronic patients, especially the most at risk patients who suffered from chronic systemic diseases of respiratory origin, such as chronic obstructive pulmonary disease (COPD) and heart disease like heart failure or complex hypertension. The application enables caregivers to inform those patients about additional precautions, to screen patients reported outcomes but also to keep in touch with them via video consultation"
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

Andrea Giammanco, FNRS Senior Research Associate

UCLouvain - FNRS
" We intend to evaluate the applicability of muon tomography for rapid and non-invasive monitoring of lung status in patients with acute pneumonia. This enhances treatment and helps to manage the flow of patients in an epidemic situation. Muons are elementary particles, freely and naturally produced in cosmic-rays interactions in the upper atmosphere. A collaboration has recently been set up between the muon tomography group of UCLouvain, the University of Tartu (UT), the National Institute for Chemical Physics and Biophysics (NICTP) in Tallinn, and the start-up company GScan, to study a new approach in muon tomography. Although originally developed for the detection of explosives and drugs in luggage-size objects (patent application PCT / EP2019 / 055333, deposited by the Estonian partners), we have indications that this method can be used to assess the lung status of covid-19 patients. The advantages of the method are: it is sensitive to material and density, there...

Bertrand Moinet, CEO - Nathalie Gillard, Dr - Eric Fichant, Dr - Patrice Filée, Dr - Jean-Noel Degeye, Ir

CER Groupe
" "As Approved Research Centre in life sciences, the CER Groupe was requested several times to participate in the action plan against Coronavirus. Among the actions taken, we can point out : • The setting up of an operational structure, qualified to carry out PCR covid-19 tests to assist local hospitals in the lockdown ending and tracing phase ; • Involvement in a Belgian consortium to develop an ELISA quantitative serological test to supplement the PCR analytical capacity and secure the lockdown ending phase ; • implementation of antibody bioproduction for therapeutic/diagnostic use. Finally, let us point out that all of these actions were possible thanks to the involvement and synergy of the CERg various operating units. - development of an ELISA quantitative serological test : design, production and characterization of antigens; design/validation of the ELISA test; production of ELISA kits - production of antibodies in various species (lamas, hens, rabbits, pigs, goats...

Denis Terwagne, Professor - Victor Lévy, Professor - Alain Delchambre, Professor - Nicolas De Coster

ULB - Fablab ULB
" A multidisciplinary team at the Fablab ULB (Université Libre de Bruxelles, Belgium) has developed and produced different open-source emergency protective solutions against Covid-19 for hospitals and caregivers. Most of these solutions have been developed within the global fablab network using digital fabrication machines (laser cutter, 3D printers,...) and open-source documentation which allowed other fablabs in the world to develop and produced these solutions locally. Face Protective Masks Face Protective Masks have been developed to protect caregivers from aerosol projection. Thanks to a lot of help (other fablabs, architectural offices, students, volunteers,...), we have produced more than 50 000 Protective Face Shields and distributed them in hospitals and to other caregivers. This project was made in collaboration with Fab-C (Charleroi), fablab Yourlab (Andenne) and the Hospital CHU Saint-Pierre in Brussels and supported by the Michel Crémer Foundation. Swabs...

Eric Haubruge, Professeur ordinaire

" Development of Methods for Mask and N95 Decontamination (the DeMaND study) and reuse for healthcare workers at the frontline The aim of this study is to identify and test, simple low-cost safe decontamination methods to enable medical masks and N95/ FFP2 respirators reuse in healthcare settings where there are critical shortages. "
Funding: Open Philanthropy
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it. 

Eric Haubruge, Professeur ordinaire - Etienne Thiry, Professeur ordinaire - Georges Daube, Professeur ordinaire

"DECONTAMINATION AND REUSE OF SURGICAL MASKS AND FILTERING FACEPIECE RESPIRATORS The global test protocol, presented in this project, aims to assess: a) the effectiveness of several decontamination methods with regard to integrity (""barrier"" function) and the quality of surgical masks and filtering facepiece respirators FFP2/N95; b) the efficacy of these decontamination methods on the inactivation of a coronavirus, similar to the SARS-CoV-2 virus present on surgical masks and filtering facepiece respirators FFP2/N95. Moreover, the present project aims to set up a consortium of companies and laboratories to meet the diverse and varied requests for ""reuse"" of various medical protective equipment (masks, filters, clothing, etc.) linked with the environmental approach."
Funding: Walloon Government
Contact: https://www.news.uliege.be/cms/c_11717821/fr/l-uliege-coordonne-le-projet-wallon-de-decontamination-des-masques-chirurgicaux-et-de-protection-respiratoire-ffp2...

Etienne CAVALIER, Professor

ULiège, CHU de Liège, CIRM
" This study aims at measuring the activity of the Angiotensin-2 enzyme (AT2) by LCMS./MS in COVID patients. This enzyme plays a key-role in the mechanisms of the infection by the SARS-COV2 "
Funding: Fondation Leon Fredericq
Contact: Professor Etienne Cavalier Department of Clinical Chemsitry University of Liège, CHU de Liège This email address is being protected from spambots. You need JavaScript enabled to view it.

Francois Mullier, Prof - Alain Dive, Prof - Michael Hardy, Dr - Sarah Lessire, Prof - Isabelle Michaux, Prof - Jonathan Douxfils, Prof

UCLouvain, CHU UCLouvain/UNamur
" Evaluation of the thrombotic risk associated with SARS-CoV-2 infection and its management in the intensive care unit: a clinical and biological longitudinal study. Background Since the beginning of SARS-CoV-2 outbreak in December 2019, data accumulate regarding the high thrombotic risk associated with this infection, which could explain substantial part of the observed morbidity and mortality (1). Accordingly, a retrospective study suggested that prophylactic anticoagulation could reduce mortality in severe COVID-19 patients with sepsis-induced coagulopathy (2). Furthermore, a European cohort reported a 27% incidence of venous thrombo-embolisms (VTEs) despite systematic prophylactic anticoagulation, raising the question whether deeper anticoagulant regimen would be beneficial in severe COVID-19 (3). Some authors also suggested that fibrinolysis alterations could be a significant determinant of SARS-CoV-2 infection's prognosis, as it is in...

Géraldine Dessilly, PhD - Benoît Kabamba, Professor

" The objective of this project is to perform SARS CoV-2 infection of cells from Vero E6 line. With a view to -Study the information of the infection on the immune activation pathways and the metabolic pathways within the cells - Perform virus viability assays in different environments and analyze the effectiveness of the hygiene measures taken to prevent transmission of the virus into the environment. - Study the neutralization and the cytopathogenic effect by antibodies from clinical samples "
Funding: own funding
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it., Professor UCLouvain/Cliniques universitaires St-Luc This email address is being protected from spambots. You need JavaScript enabled to view it., PhD UCLouvain

Gilles Bruylants, Professor - Ivan Jabin, Professor - Vincent Raussens, Professor

" This project aims at developing soluble anti-SARS-CoV-2 virus immunoglobins (IgM and IgG) detection systems based on calixarene coated silver nanoparticles functionalized with viral antigens. These particles could advantageously replace gold nanoparticles (10x more efficient in light extinction) in Lateral Flow ImmunoAssays and Immunoturbidimetry tests. "
Funding: ULB Special COVID-19 Call
Publication References: "Controlled Functionalisation of Gold Nanoparticles with Mixtures of Calix[4]arenes revealed by Infra-red Spectroscopy". Valkenier, H.; Malytskyi, V.; Blond, P.; Retout, M.; Mattiuzzi, A.; Goole, J.; Raussens, V.; Jabin, I.; Bruylants, G., Langmuir 2017, 33, 8253-8259. "Extremely robust and post-functionalizable gold nanoparticles coated with calix[4]arenes via metal–carbon bonds". Troian-Gautier, L.; Valkenier, H.; Mattiuzzi, A.; Jabin, I.; Van den Brande, N.; Van Mele, B.; Hubert, J.; Reniers, F.; Bruylants, G.; Lagrost, C.; Leroux, Y., Chem. Commun. 2016, 52...

Greet Kerckhofs, Professor

" According to current guidelines from several health organization, the use of (homemade) textile face masks is recommended in order to slow the spread of the COVID-19. Currently, however, guidelines are very limited regarding the textiles to use (for the envelope), and the best suited filter material to be used in these types of masks. The general goal of this project is to provide reliable, consistent and science-based recommendations and guidelines about the preferred design for (homemade) textile face masks, as well as about the preferred materials to use for the textile envelope and the filter material. We will first determine the microstructure of different materials, giving us information on the filter efficiency (mechanical) and breathability of different materials and masks. Then, we will investigate the variability in filter efficiency and breathability of different material combinations. Finally, we will assess the aging of the filter material under humid...

Haruko Takeda, Senior Scientist

Development of rapid and reliable alternative diagnostics for wide-scale COVID-19 testing. " Wide-scale implementation of rapid, reliable, low-cost diagnostic tests would help epidemic containment and mitigation strategies. The current gold standard in COVID-19 diagnostics employs quantitative reverse transcription (qRT) PCR which through cyclic reactions at different temperatures detects segments of the SARS-CoV-2 genome from RNA extracts from nasopharyngeal swabs. Though reliable, this procedure requires special sampling devices, purification of RNA, qualified personnel, sophisticated equipment, and a six hour turnaround time to result. By leveraging on university expert capacities such as molecular biology and protein science, our team has performed a series of controlled experiments to assess the specificity and sensitivity of loop- mediated isothermal amplification (LAMP)- and recombinase polymerase amplification (RPA)-based tests in comparison with the qRT-PCR procedure...

Jean Ruelle, Dr. - Anaïs Scohy, Clinical biologist - Benoît Kabamba, Pr.

" Thanks to high-throughput sequencing of the strains collected for the diagnosis, we document the viral spread within health care facilities. A better understanding of the virus transmission chains are key to evaluate the efficacy of hygiene measures that were implemented to avoid cross-contamination between patients and health care workers. A secondary objective is the analysis of clinical data related to the patients, in order to search genotypic differences that may possibly explain divergent pathogenic courses. "
Funding: Own funding, submitted calls.
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it., PhD Chercheur qualifié at UCLouvain/IREC/MBLG This email address is being protected from spambots. You need JavaScript enabled to view it., Clinical biologist at Cliniques universitaires St-Luc This email address is being protected from spambots. You need JavaScript enabled to view it., Professor UCLouvain/Cliniques universitaires St-Luc

Jean-François Focant, Professor

" I am leading the Organic and Biological Analytical Chemistry laboratory. This research group is specialized in developing integrated solution for biological samples characterization, especially non-targeted screening. We also develop method for target studies in different sample types. "
Publication References: F. Schleich, D. Zanella, P.-H. Stefanuto, K. Bessonov, A. Smolinska, J.W. Dallinga, M. Henket, V. Paulus, F. Guissard, S. Graff, C. Moermans, E.F.M. Wouters, K. Van Steen, F.-J. van Schooten, J.-F. Focant, R. Louis, Exhaled Volatile Organic Compounds Are Able to Discriminate between Neutrophilic and Eosinophilic Asthma. Am. J. Respir. Crit. Care Med. 2019, 200, 444-453. (10.1164/rccm.201811-2210OC) R. Pesesse, P.-H. Stefanuto, F. Schleich, R. Louis, J.-F. Focant, Multimodal Chemometric Approach for the Analysis of Human Exhaled Breath in Lung Cancer Patients by TD-GC×GC-TOFMS. J. Chromatogr. B 2019, 1114, 146-153. (10.1016/j.jchromb.2019.01.029) D. Zanella, P.-H...

Contact us

c/o F.R.S. - FNRS

Rue d’Egmont 5

B - 1000 Bruxelles

Tél : +32 2 504 92 11


Brussels & Wallonia against COVID19